Cargando…
A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity
Endpoint: To assess early urinary (GU) and rectal (GI) toxicities after helical tomotherapy Stereotactic body radiation therapy (SBRT), and to determine their predictive factors. Methods: Since May 2012, 45 prostate cancer patients were treated with eight fractions of 5.48 (low risk, 29%) or 5.65 Gy...
Autores principales: | Macias, Victor A., Blanco, Manuel L., Barrera, Inmaculada, Garcia, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244529/ https://www.ncbi.nlm.nih.gov/pubmed/25505734 http://dx.doi.org/10.3389/fonc.2014.00336 |
Ejemplares similares
-
Measurement‐guided volumetric dose reconstruction for helical tomotherapy
por: Stambaugh, Cassandra, et al.
Publicado: (2015) -
Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma
por: Song, Jin Ho, et al.
Publicado: (2015) -
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage
por: Bae, Sun Hyun, et al.
Publicado: (2021) -
Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014) -
Critical Structure Sparing in Stereotactic Ablative Radiotherapy for Central Lung Lesions: Helical Tomotherapy vs. Volumetric Modulated Arc Therapy
por: Chi, Alexander, et al.
Publicado: (2013)